Christopher G. Micetich
President, Founder, and CEO at Brass Dome Ventures Ltd. and Fedora Pharmaceuticals Inc.

Christopher presently serves as President & CEO of both Fedora Pharmaceuticals Inc. and Brass Dome Ventures Ltd. Fedora Pharmaceuticals Inc. is an anti-infective drug discovery company founded in 2011. In 2014, Fedora signed the at-the-time largest licensing deal ever signed in Canadian biotech history, licensing their beta-lactamase inhibitor to Hoffman J La Roche for US$750 million in addition to royalties. Fedora continues the pursuit of developing new drugs that save lives. Brass Dome Ventures Ltd. was founded in 2016 and employs a multi-disciplinary team of business experts.

He has received numerous prestigious awards, including: Ernst & Young Entrepreneur of the Year Award, BioAlberta Company of the Year Award, and Astech Commercial Achievement Award.